GENETIC TECHNOLOGIES (GENE)
News
| May 28 | @super_trades do you think ROSG will drag $GENE higher? I have small short on GENE by ivan_bg |
| May 26 | $GENE gapped down 15% even after ending wed highs and $GNOM gapped up. risk mgnt lesson. by neoalvaro |
| May 25 | RT @slimtrader $AMLN $GNOM $ROSG $GENE - So the rumor is Roche acquires $GNOM this weekend? by slimtrader |
| May 25 | $GNOM $ROSG $GENE - So the rumor is Roche acquires $GNOM this weekend? by slimtrader |
| May 25 | Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower Street Insider |
| May 25 | $GENE I think it will hit 4.85 soon, having low vol by Kutty |
| May 25 | VeriFone Systems, VimpelCom Among Stocks Down on High Volume Friday Fox Business |
| May 25 | $GENE i would lock in profits before it goes down before close.... this was a classic pump and dump... dont get caught holding the bag.... by shaun20 |
| May 25 | $GENE people are just hanging on hoping it runs like yesterday..... Market will sell off into close like every friday before memorial wkend by shaun20 |
| May 25 | $GENE will buy again @ 3.75 by shaun20 |
| May 25 | Morning Movers 05/25: (GNOM) (UPI) (EJ) Higher; (DCTH) (TLB) (GENE) Lower Street Insider |
| May 25 | VeriFone Systems, Rosetta Genomics Among Stocks Gapping Down Friday Fox Business |
| May 25 | Pre-Open Movers 5/25: (BLOX) (FRO) (QSFT) Higher; (TLB) (ROSG) (DCTH) Lower (more...) Street Insider |
Profile
Exchange: NASDAQGM Sector: Services Industry: Research Services
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GENETIC TECHNOLOGIES is down 27.81% over the last year vs S&P 500 Total Return up 1.18%, Complete Genomics down 80.18%, and Myriad Genetics up 0.51%.
- GENE Total Returns
- ^SPXTR Total Returns
- GNOM Total Returns
- MYGN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
You may also be interested in these GENE related companies
Pro Strategies Featuring GENE
Did GENETIC TECHNOLOGIES make it into our Pro Portfolio Strategies?
GENE Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other GENE Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GENE | 5.45 | +0.63 | +13.07% | 74.66M |
| GENC | 7.15 | +0.03 | +0.42% | 57.27M |
| GEN | 1.79 | +0.01 | +0.56% | 1.374B |
| GEL | 29.92 | +0.19 | +0.64% | 2.339B |
| GEFB | 45.97 | +0.20 | +0.44% | 1.017B |
| GEF | 45.20 | +0.71 | +1.60% | 2.102B |
| GE | 19.30 | +0.10 | +0.52% | 203.16B |
| GDXJ | 20.27 | +0.24 | +1.20% | |
| GDX | 45.30 | +0.39 | +0.87% | |
| GDV | 15.07 | +0.10 | +0.67% |
